Column Group Entities Complete Full Exit from Tenaya Therapeutics Position

This Amendment No. 7 to Schedule 13D filed by The Column Group entities reports the complete divestment of their remaining holdings in Tenaya Therapeutics, Inc. The filing documents that The Column Group III, LP and The Column Group III-A, LP have sold all their shares through multiple transactions between February 20-25, 2026, totaling approximately 2.9 million shares for an aggregate value of around $1.6 million. The sales were executed at weighted-average prices ranging from $0.5624 to $0.6153 per share. Following these transactions, these entities now hold zero shares, representing a complete exit from their position. The filing also adds Tim Kutzkey and Peter Svennilson as reporting persons due to management changes. The Column Group Opportunity III, LP continues to hold 49.3 million shares (23.1% ownership) along with warrants for 53.6 million additional shares.